Fourth study published over two-year span that analyzes key leukemia protein
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes & Development.
When a key protein responsible for leukemia, MLL, is stabilized, it slows the progression of the leukemia, the most recent study found. The next step will be to combine the treatments from the past two years of research into a pediatric leukemia “super drug” to test on humans in a clinical trial.
The survival rate is only 30 percent for children diagnosed with MLL-translocation leukemia, a cancer that affects the blood and bone marrow. Patients with leukemia have a very low percentage of red blood cells, making them anemic, and have approximately 80 times more white blood cells than people without cancer.
30%Current survival rate for pediatric leukemia patients.
“These white blood cells infiltrate many of the tissues and organs of the affected individuals and is a major cause of death in leukemia patients,” said senior author Ali Shilatifard, the Robert Francis Furchgott Professor of Biochemistry and Molecular Genetics and Pediatrics, the chairman of biochemistry and molecular genetics and the director of Northwestern’s Simpson Querrey Center for Epigenetics. “This is a monster cancer that we’ve been dealing with for many years in children.”
There are several types of leukemia. This research focused on the two most common found in infants through teenagers: acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).
For the past 25 years, Shilatifard’s laboratory has been studying the molecular function of MLL within its complex known as COMPASS (Complex Proteins Associated with Set1). Most recently, it was demonstrated that COMPASS components are one of the most frequently identified mutations in cancer.The next step of this work will be to bring the drug to a clinical trial setting, which Shilatifard said he hopes will happen in the next three to five years.
“I’ve been working on this translocation for more than two decades, and we’re finally at the point where in five to 10 years, we can get a drug in kids that can be effective,” Shilatifard said. “If we can bring that survival rate up to 85 percent, that’s a major accomplishment.”
Earlier work from Shilatifard’s laboratory published in Cell in 2018 identified compounds that could slow cancer growth by interrupting a gene transcription process known as “Super Elongation Complex” (SEC). It was the first compound in its class to do this.
This MLL stabilization process discovered in the most recent paper could potentially work in cancers with solid tumors, such as breast or prostate cancer, said first author Zibo Zhao, a postdoctoral research fellow in Shilatifard’s lab.
“This opens up a new therapeutic approach not only for leukemia, which is so important for the many children who are diagnosed with this terrible cancer, but also for other types of cancers that plague the population,” Zhao said.
“The publication of these four papers and the possibility of a future human clinical trial could not have happened if it weren’t for the cross-disciplinary collaboration at Northwestern,” Shilatifard said.
Learn more: Pediatric leukemia ‘super drug’ could be developed in the coming years
The Latest on: Pediatric leukemia
[google_news title=”” keyword=”pediatric leukemia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pediatric leukemia
- Cindy Crawford struggled with survivors guilt following her brother's death from leukemiaon May 13, 2024 at 1:50 pm
Crawford described what it was like growing up in a home with a sick sibling, revealing that she and her sisters weren't entirely privy to the severity of her brother's condition – he was battling ...
- Cindy Crawford’s Family Guide: Meet Her Husband, Children, Parents and Moreon May 13, 2024 at 11:19 am
Cindy Crawford has always put her family first on her way to becoming one of the industry’s most legendary models. Crawford and Rande Gerber, who tied the knot in 1998, share son Presley Gerber and ...
- Children born after fresh and frozen embryo transfers at increased leukemia risk than children conceived naturally: JAMAon May 13, 2024 at 10:00 am
The study findings suggest that children born after FET or fresh ET had an increased leukemia risk compared with children conceived naturally. There is a need to monitor this risk, although resulting ...
- Oregon Ducks, Washington Huskies Fans Come Together in Fight Against Leukemiaon May 12, 2024 at 5:00 pm
Evie’s condition worsened and she was taken to Randall Children’s Hospital at Legacy Emanuel in Portland where doctors were again unable to find out what was wrong. Just a few short weeks after this, ...
- ‘My faith is definitely my rock’: Jasper pitcher leans on faith through battle with Leukemiaon May 11, 2024 at 12:58 am
My faith is definitely my rock, it keeps you anchored in hard times,” said Elise. And she stayed anchored, and determined. Determined to get back on the softball field. “There was no doubt she was ...
- ‘Little Heroes Prom’ brings pediatric cancer patients together for a night of funon May 10, 2024 at 8:18 pm
The “Little Heroes Prom” was held in New Brunswick Friday night. The event brought pediatric cancer patients from all over the state to a special event. The theme this year was “Under the Big Top.” It ...
- A New Kid on the Block of Therapy for Acute Myeloid Leukemiaon May 9, 2024 at 5:02 am
Crenolanib may have advantages over other therapies targeting acute myeloid leukemia with FLT3 gene mutations.
- How Long Do You Have To Live With Leukemia? A Review By Doctorson May 7, 2024 at 2:28 pm
Expert opinion from Marcella Abunahman Pereira Specialization in Clinical Cardiology · 12 years of experience · Brazil Leukemia is a cancer that involves the white blood cells which are potent to ...
- Medically aided conception vs. natural conception: Study explores cancer risk in childrenon May 7, 2024 at 3:29 am
Study: Medically Assisted Reproduction and Risk of Cancer Among Offspring. Image Credit: Antonio Guillem/Shutterstock.com. Background. Childhood cancers are a global health proble ...
- Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapyon May 4, 2024 at 11:01 am
The study serves as a proof of principle of how to take non-coding DNA variants and mechanistically connect them to a trait, such as chemotherapy resistance. That has been a long-standing issue ...
via Bing News